CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro

Archivum Immunologiae et Therapiae Experimentalis

Volumn 57, Issue 6, 2009, Pages 447-458

  Néron, Sonia ^a,b   Boire, Gilles ^c   Dussault, Nathalie ^a   Racine, Claudia ^a   De Brum Fernandes, Artur J ^c   Côté, Serge ^a,b   Jacques, Annie ^a  

^a HÉMA QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

B cell; Differentiation; Intravenous immunoglobulins; IVIg; SLE

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CLONAL ANERGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED;

EID: 70450280581     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-009-0048-3     Document Type: Article

References (68)

1. F Agenes MM Rosado AA Freitas 2000 Peripheral B cell survival Cell Mol Life Sci 57 1220 1228 10.1007/PL00000761 11028914
2. JH Anolik J Barnard A Cappione, et al. 2004 Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus Arthritis Rheum 50 3580 3590 10.1002/art.20592 15529346 (Pubitemid 39488683)
3. RM Anthony F Nimmerjahn DJ Ashline, et al. 2008 Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc Science 320 373 376 10.1126/science.1154315 18420934 (Pubitemid 351555659)
4. E Arce DG Jackson MA Gill, et al. 2001 Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J Immunol 167 2361 2369 11490026
5. J Banchereau P de Paoli A Valle, et al. 1991 Long-term human B cell lines dependent on interleukin-4 and antibody to CD40 Science 251 70 72 10.1126/science.1702555 1702555
6. DW Branch TF Porter MJ Paidas, et al. 2001 Obstetric uses of intravenous immunoglobulin: Successes, failures, and promises J Allergy Clin Immunol 108 S133 S138 10.1067/mai.2001.117821 11586281 (Pubitemid 32978011)
7. G Cambridge MJ Leandro M Teodorescu, et al. 2006 B cell depletion therapy in systemic lupus erythematosus - effect on autoantibody and antimicrobial antibody profiles Arthritis Rheum 54 3612 3622 10.1002/art.22211 17075806 (Pubitemid 44737173)
8. AJ Cappione AE Pugh-Bernard JH Anolik, et al. 2004 Lupus IgG V(H)4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes J Immunol 172 4298 4307 15034044
9. RH Carter H Zhao X Liu, et al. 2005 Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus Arthritis Rheum 52 3943 3954 10.1002/art.21489 16320342 (Pubitemid 41798234)
10. MJ de Grandmont C Racine A Roy, et al. 2003 Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG Blood 101 3065 3073 10.1182/blood-2002-06-1684 12480708 (Pubitemid 36857997)
11. DJ Dilillo Y Hamaguchi Y Ueda, et al. 2008 Maintenance of long-lived plasma cells and serological memory despite mature and memory b cell depletion during CD20 immunotherapy in mice J Immunol 180 361 371 18097037
12. CB Driver M Ishimori MH Weisman 2008 The B cell in systemic lupus erythematosus: a rational target for more effective therapy Ann Rheum Dis 67 1374 1381 10.1136/ard.2007.076745 17720723
13. N Dussault E Ducas C Racine, et al. 2008 Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2 Int Immunol 20 1369 1379 10.1093/intimm/dxn090 18689724
14. JF Fecteau S Néron 2003 CD40 stimulation of human peripheral B lymphocytes: distinct response from nanve and memory cells J Immunol 171 4621 4629 14568936
15. DD Gladman CH Goldsmith MB Urowitz, et al. 2000 The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison J Rheumatol 27 373 376 10685799
16. R Gonzalez-Amaro D Portales-Perez L Baranda, et al. 1998 Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus J Autoimmun 11 395 402 10.1006/jaut.1998.0228 9802922 (Pubitemid 28520194)
17. AC Grammer PE Lipsky 2002 CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus Arthritis Rheum 46 1417 1429 10.1002/art.10287 12115170 (Pubitemid 34620186)
18. Grammer AC, Lipsky PE (2003) B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 5(suppl 4):S22-27
19. AC Grammer R Slota R Fischer, et al. 2003 Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions J Clin Invest 112 1506 1520 14617752
20. Y Harada MM Kawano N Huang, et al. 1996 Identification of early plasma cells in peripheral blood and their clinical significance Br J Haematol 92 184 191 10.1046/j.1365-2141.1996.300835.x 8562394
21. M Harigai M Hara C Fukasawa, et al. 1999 Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus Lupus 8 227 233 10.1191/096120399678847678 10342716
22. G Hawker S Gabriel C Bombardier, et al. 1993 A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus J Rheumatol 20 657 660 8496860 (Pubitemid 23138854)
23. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 10.1002/art.1780400928 9324032
24. DA Isenberg C McClure V Farewell, et al. 1998 Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus Ann Rheum Dis 57 566 570 10.1136/ard.57.9.566 9849317
25. AM Jacobi M Odendahl K Reiter, et al. 2003 Correlation between circulating CD27(high) plasma cells and disease activity in patients with systemic lupus erythematosus Arthritis Rheum 48 1332 1342 10.1002/art.10949 12746906 (Pubitemid 36554532)
26. SV Kaveri G Dietrich V Hurez, et al. 1991 Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases Clin Exp Immunol 86 192 198 1934588
27. MD Kazatchkine G Dietrich V Hurez, et al. 1994 V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig) Immunol Rev 139 79 107 10.1111/j.1600-065X.1994.tb00858.x 7927415
28. DM Klinman A Shirai J Conover, et al. 1994 Cross-reactivity of IgG anti-DNA-secreting B cells in patients with systemic lupus erythematosus Eur J Immunol 24 53 58 10.1002/eji.1830240109 8020571 (Pubitemid 24014677)
29. M Koshy D Berger MK Crow 1996 Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes J Clin Invest 98 826 837 10.1172/JCI118855 8698875 (Pubitemid 26349188)
30. L Le Pottier B Bendaoud M Dueymes, et al. 2007 BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer J Clin Immunol 27 257 265 10.1007/s10875-007-9082-2 17393290 (Pubitemid 46790821)
31. MH Liang SA Socher MG Larson, et al. 1989 Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Arthritis Rheum 32 1107 1118 10.1002/anr.1780320909 2775320
32. L Mandik-Nayak N Ridge M Fields, et al. 2008 Role of B cells in systemic lupus erythematosus and rheumatoid arthritis Curr Opin Immunol 20 639 645 10.1016/j.coi.2008.08.003 18775493
33. LJ McHeyzer-Williams LP Malherbe MG McHeyzer-Williams 2006 Checkpoints in memory B-cell evolution Immunol Rev 211 255 268 10.1111/j.0105-2896.2006.00397. x 16824133 (Pubitemid 43882977)
34. Morell A (1997) Pharmacokinetics of intravenous immunoglobulin preparations. In: Lee ML, Strand V (eds) Intravenous immunoglobulins in clinical practice. Marcel Dekker, Inc., New-York, NY, pp 1-18
35. I Mori C Parizot K Dorgham, et al. 2008 Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barre syndrome PLoS ONE 3 e2109 10.1371/journal.pone.0002109 18461177 (Pubitemid 352025142)
36. H Nagafuchi Y Shimoyama J Kashiwakura, et al. 2003 Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus Clin Exp Rheumatol 21 71 77 12673892
37. VS Negi S Elluru S Siberil, et al. 2007 Intravenous immunoglobulin: An update on the clinical use and mechanisms of action J Clin Immunol 27 233 245 10.1007/s10875-007-9088-9 17351760 (Pubitemid 46790823)
38. S Néron N Dussault C Racine 2006 Whole-blood leukoreduction filters are a source for cryopreserved cells for phenotypic and functional investigations on peripheral blood lymphocytes Transfusion 46 537 544 10.1111/j.1537-2995.2006.00772.x 16584429
39. S Néron A Pelletier MC Chevrier, et al. 1996 Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand Immunol Invest 25 79 89 10.3109/08820139609059292 8675236
40. S Néron C Racine A Roy, et al. 2005 Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction Immunology 116 454 463 16313359
41. S Néron L Thibault N Dussault, et al. 2007 Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells Transfusion 47 1042 1049 10.1111/j.1537-2995.2007.01233.x 17524095 (Pubitemid 46802086)
42. F Nimmerjahn JV Ravetch 2008 Fcgamma receptors as regulators of immune responses Nat Rev Immunol 8 34 47 10.1038/nri2206 18064051
43. M Odendahl A Jacobi A Hansen, et al. 2000 Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J Immunol 165 5970 5979 11067960
44. AE Pugh-Bernard JC Cambier 2006 B cell receptor signaling in human systemic lupus erythematosus Curr Opin Rheumatol 18 451 455 10.1097/01.bor. 0000240353.99808.5f 16896281 (Pubitemid 44200326)
45. AE Pugh-Bernard GJ Silverman AJ Cappione, et al. 2001 Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance J Clin Invest 108 1061 1070 11581307
46. C Putterman 2004 New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus Autoimmun Rev 3 7 11 10.1016/S1568-9972(03)00082-X 15003182 (Pubitemid 38293360)
47. A Radbruch G Muehlinghaus EO Luger, et al. 2006 Competence and competition: the challenge of becoming a long-lived plasma cell Nat Rev Immunol 6 741 750 10.1038/nri1886 16977339 (Pubitemid 44453460)
48. A Roy E Krzykwa R Lemieux, et al. 2001 Increased efficiency of gamma-irradiated versus mitomycin C-treated feeder cells for the expansion of normal human cells in long-term cultures J Hematother Stem Cell Res 10 873 880 10.1089/152581601317210962 11798513 (Pubitemid 34081315)
49. S Sato M Fujimoto M Hasegawa, et al. 2004 Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells Arthritis Rheum 50 1918 1927 10.1002/art.20274 15188368 (Pubitemid 38725103)
50. JF Seite Y Shoenfeld P Youinou, et al. 2008 What is the contents of the magic draft IVIg? Autoimmun Rev 7 435 439 10.1016/j.autrev.2008.04.012 18558358
51. Y Sherer Y Shoenfeld 2006 Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus Autoimmun Rev 5 153 155 10.1016/j.autrev.2005. 09.002 16431350 (Pubitemid 43129550)
52. Y Sherer Y Shoenfeld 2006 Mechanisms of disease: atherosclerosis in autoimmune diseases Nat Clin Pract Rheumatol 2 99 106 10.1038/ncprheum0092 16932663 (Pubitemid 43239209)
53. Y Shoenfeld U Katz 2005 IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients Autoimmunity 38 123 137 10.1080/08916930500059633 16040333 (Pubitemid 40872737)
54. Y Shoenfeld L Rauova B Gilburd, et al. 2002 Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus Int Immunol 14 1303 1311 10.1093/intimm/dxf099 12407021 (Pubitemid 35331427)
55. KH Sun CL Yu SJ Tang, et al. 2000 Monoclonal anti-double- stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis Immunology 99 352 360 10.1046/j.1365-2567.2000.00970.x 10712664 (Pubitemid 30137699)
56. SG Tangye VL Bryant AK Cuss, et al. 2006 BAFF, APRIL and human B cell disorders Semin Immunol 18 305 317 10.1016/j.smim.2006.04.004 16916610 (Pubitemid 44287555)
57. T Tha-In J Bayry HJ Metselaar, et al. 2008 Modulation of the cellular immune system by intravenous immunoglobulin Trends Immunol 29 608 615 10.1016/j.it.2008.08.004 18926775
58. E Toubi A Kessel Y Shoenfeld 2005 High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus Hum Immunol 66 395 402 10.1016/j.humimm.2005.01.022 15866703 (Pubitemid 40615795)
59. E Toubi Y Shoenfeld 2004 BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus Isr Med Assoc J 6 99 102 14986468
60. E Toubi Y Shoenfeld 2004 The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway Autoimmunity 37 457 464 10.1080/08916930400002386 15621572 (Pubitemid 40123415)
61. C Van Kooten J Banchereau 2000 CD40-CD40 ligand J Leukoc Biol 67 2 17 10647992
62. J Vani S Elluru VS Negi, et al. 2008 Role of natural antibodies in immune homeostasis: IVIg perspective Autoimmun Rev 7 440 444 10.1016/j.autrev.2008.04. 011 18558359
63. C Wei J Anolik A Cappione, et al. 2007 A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus J Immunol 178 6624 6633 17475894
64. CH Wouters C Diegenant JL Ceuppens, et al. 2004 The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship Br J Dermatol 150 693 700 10.1111/j.0007-0963.2004.05883.x 15099365 (Pubitemid 38586220)
65. G Zandman-Goddard Y Levy Y Shoenfeld 2005 Intravenous immunoglobulin therapy and systemic lupus erythematosus Clin Rev Allergy Immunol 29 219 228 10.1385/CRIAI:29:3:219 16391397 (Pubitemid 43041673)
66. J Zhang V Roschke KP Baker, et al. 2001 Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus J Immunol 166 6 10 11123269
67. R Zimmerman J Radhakrishnan A Valeri, et al. 2001 Advances in the treatment of lupus nephritis Ann Rev Med 52 63 78 10.1146/annurev.med.52.1.63 11160768 (Pubitemid 32195315)
68. M Zouali 2005 Taming lupus Sci Am 292 58 65 10.1038/ scientificamerican0305-70 15859214